DOI: 10.1055/s-00000129

Kardiologie up2date

References

Zinman B, Wanner C, Lachin JM. et al.
Empaglifozin, cardiovascular outcomes, and mortality in type 2 diabetes.

N Engl J Med 2015;
373: 2117-2128

Zinman B, Wanner C, Lachin JM. et al.
Empaglifozin, cardiovascular outcomes, and mortality in type 2 diabetes.

N Engl J Med 2015;
373: 2117-2128

Download Bibliographical Data

Search in:
Access: